Efficacy of sorafenib on metastatic renal cell carcinoma in Asian patients: Results from a multicenter study
10.1186/1471-2407-9-249
Saved in:
Main Authors: | Lu, J.J., Yao, X., Zhang, S., Dai, B., Shen, Y., Zhu, Y., Ye, D., Huang, Y., Zhang, H., Dong, B. |
---|---|
Other Authors: | MEDICINE |
Format: | Article |
Published: |
2016
|
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/129777 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Survival outcomes of metastatic/unresectable hepatocellular carcinoma in patients treated with sorafenib
by: J. Chantharasamee, et al.
Published: (2020) -
Multicenter phase II study of sequential radioembolization-sorafenib therapy for inoperable hepatocellular carcinoma
by: Chow, P.K.H., et al.
Published: (2016) -
Sorafenib efficacy in ovarian clear cell carcinoma revealed by transcriptome profiling
by: Matsumura, N., et al.
Published: (2014) -
Combination of the ERK inhibitor AZD6244 and low-dose sorafenib in a xenograft model of human renal cell carcinoma
by: Yuen, J.S.P, et al.
Published: (2020) -
Variation in use of targeted therapies for metastatic renal cell carcinoma: Results from a Dutch population-based registry
by: De Groot, S, et al.
Published: (2020)